Paper39670906
[Monoclonal Antibodies in Allergic Diseases: Development, Pharmacology, and Clinical Applications]
Pury S and 8 others. Rev Fac Cien Med Univ Nac Cordoba, 2024. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. [Monoclonal Antibodies in Allergic Diseases: Development, Pharmacology, and Clinical Applications]. Papers, record 39670906. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39670906
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- [Monoclonal Antibodies in Allergic Diseases: Development, Pharmacology, and Clinical Applications]
- PubMed
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Monoclonal | Major topic |
| Hypersensitivity | Major topic |
| Humans | |
| Animals |
Source PubMed
References49
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 3085297 | Monoclonal antibody therapy. Anti-idiotypic and non-anti-idiotypic antibodies to OKT3 arising despite intense immunosuppression. | Transplantation | 1986 | https://conductscience.org/library/papers/3085297 | PubMed |
| 2 | 8075633 | Antigen-specific human monoclonal antibodies from mice engineered with human Ig heavy and light chain YACs. | Nat Genet | 1994 | https://conductscience.org/library/papers/8075633 | PubMed |
| 3 | 33965091 | Roles of innate lymphoid cells (ILCs) in allergic diseases: The 10-year anniversary for ILC2s. | J Allergy Clin Immunol | 2021 | https://conductscience.org/library/papers/33965091 | PubMed |
| 4 | 37684154 | Current and Novel Biologic Therapies for Patients with Asthma and Nasal Polyps. | Otolaryngol Clin North Am | 2024 | https://conductscience.org/library/papers/37684154 | PubMed |
| 5 | 32494573 | The role of interleukin-17 in asthma: a protective response? | ERJ Open Res | 2020 | https://conductscience.org/library/papers/32494573 | PubMed |
| 6 | 36829616 | Bioengineering of Antibody Fragments: Challenges and Opportunities. | Bioengineering (Basel) | 2023 | https://conductscience.org/library/papers/36829616 | PubMed |
| 7 | 11880051 | Emil von Behring and serum therapy. | Microbes Infect | 2002 | https://conductscience.org/library/papers/11880051 | PubMed |
| 8 | 9048207 | Finally! The Brambell receptor (FcRB). Mediator of transmission of immunity and protection from catabolism for IgG. | Immunol Res | 1997 | https://conductscience.org/library/papers/9048207 | PubMed |
| 9 | 33923629 | Molecular Mechanisms of Atopic Dermatitis Pathogenesis. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33923629 | PubMed |
| 10 | 30206782 | Understanding Asthma Phenotypes, Endotypes, and Mechanisms of Disease. | Clin Rev Allergy Immunol | 2019 | https://conductscience.org/library/papers/30206782 | PubMed |
| 11 | 31793004 | Concept of Pharmacologic Target-Mediated Drug Disposition in Large-Molecule and Small-Molecule Compounds. | J Clin Pharmacol | 2020 | https://conductscience.org/library/papers/31793004 | PubMed |
| 12 | 37679612 | Antibody Phage Display. | Methods Mol Biol | 2023 | https://conductscience.org/library/papers/37679612 | PubMed |
| 13 | 36669622 | Mechanisms underlying the efficacy and safety of IgG, antibody fragments, and design immune biologics. | J Allergy Clin Immunol | 2023 | https://conductscience.org/library/papers/36669622 | PubMed |
| 14 | 8159246 | Antigen-specific human antibodies from mice comprising four distinct genetic modifications. | Nature | 1994 | https://conductscience.org/library/papers/8159246 | PubMed |
| 15 | 32586877 | Treatment options in type-2 low asthma. | Eur Respir J | 2021 | https://conductscience.org/library/papers/32586877 | PubMed |
| 16 | 37240477 | Pathobiology of Type 2 Inflammation in Asthma and Nasal Polyposis. | J Clin Med | 2023 | https://conductscience.org/library/papers/37240477 | PubMed |
| 17 | 17636457 | Physiologically-based pharmacokinetic (PBPK) model to predict IgG tissue kinetics in wild-type and FcRn-knockout mice. | J Pharmacokinet Pharmacodyn | 2007 | https://conductscience.org/library/papers/17636457 | PubMed |
| 18 | 36448493 | Chronic spontaneous urticaria: Focus on pathophysiology to unlock treatment advances. | Allergy | 2023 | https://conductscience.org/library/papers/36448493 | PubMed |
| 19 | 1172191 | Continuous cultures of fused cells secreting antibody of predefined specificity. | Nature | 1975 | https://conductscience.org/library/papers/1172191 | PubMed |
| 20 | 24200404 | Randomized, double-blind, placebo-controlled study of brodalumab, a human anti-IL-17 receptor monoclonal antibody, in moderate to severe asthma. | Am J Respir Crit Care Med | 2013 | https://conductscience.org/library/papers/24200404 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39670906
GET https://conductscience.org/api/papers/v1/39670906/references?page=2